Tweets
Cochrane review of Stem cell transplantation in systemic sclerosis (3RCTs w/ 125 pts). Non‐myeloablative & myeloablative selective HSCT had moderate evidence for improved survival, skin thickness & function. But these had high Serious AE rates. https://t.co/VKciXY0klN https://t.co/LdMu3RrlZK
Links:
Donald Thomas, MD @lupuscyclopedia ( View Tweet )
Leonard Calabrese @LCalabreseDO ( View Tweet )
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:


